Hashimoto's lab panel: how to read your results
Anchor biomarkers: TSH, free T4, TPO antibodies
TL;DR
- •TSH alone doesn't tell the story. Most patients with Hashimoto's are diagnosed on the pattern across TSH + free T4 + TPO antibodies — not any one of those numbers.
- •A 'normal' TSH can hide active autoimmune thyroid disease. TPO antibodies often elevate years before TSH moves.
- •The trajectory matters more than the snapshot. Two TSH values six months apart tell you something a single result cannot.
What each marker tells you
| Marker | Reference range | What it means |
|---|---|---|
| TSH (thyroid stimulating hormone) | 0.4 – 4.5 mIU/L | The brain's signal asking the thyroid to make more hormone. High TSH = brain is shouting because the thyroid is underperforming. |
| Free T4 (thyroxine) | 0.8 – 1.8 ng/dL | The actual circulating thyroid hormone available to your tissues. Low = hypothyroid in practice. |
| Free T3 (triiodothyronine) | 2.3 – 4.2 pg/mL | The active form of thyroid hormone at the cellular level. Sometimes normal while T4 is low. |
| TPO antibodies (thyroid peroxidase Ab) | < 35 IU/mL | The autoimmune signal. Elevated = your immune system is attacking the thyroid. Defines Hashimoto's specifically. |
| Thyroglobulin antibodies (TgAb) | < 20 IU/mL | A second autoimmune signal. Some patients have one elevated, some have both. |
| Reverse T3 | 9 – 24 ng/dL | A stress-response form of thyroid hormone. Often elevated under chronic illness or undernutrition. |
Reference ranges are lab-dependent. LabCorp, Quest, and hospital labs each publish slightly different cutoffs. The values above are common US ranges; your lab's printed range is the one to compare against.
Three real patterns Phi has seen
Example patterns · synthetic data drawn from Phi's scenario library. Not real patient records.
Pattern 1 — The "your labs are normal" pattern.
TSH 2.8 (in range). Free T4 1.2 (in range). TPO antibodies 412 (elevated). A primary-care visit reads "normal thyroid function" because TSH and T4 sit in range. But the elevated TPO is telling: the autoimmune process is active. This patient often presents with fatigue, brain fog, and intermittent weight changes, and is told nothing's wrong with their thyroid. The right read: subclinical Hashimoto's, watch the trajectory, address the autoimmune driver (sleep, stress, gluten/dairy trial, vitamin D).
Example pattern · synthetic data
Pattern 2 — The "slipping into hypothyroid" pattern.
TSH 6.8 (mildly elevated). Free T4 0.9 (low-normal). TPO antibodies 890 (high). Free T3 2.4 (low-normal). This is full Hashimoto's progressing toward overt hypothyroid. Most endocrinologists initiate or adjust levothyroxine here. The thing patients miss: Free T3 conversion may stay sluggish even after T4 normalizes on medication — which is why some patients on "adequate" T4 still feel tired.
Example pattern · synthetic data
Pattern 3 — The "treated but still symptomatic" pattern.
TSH 1.4 (good, on med). Free T4 1.5 (mid-range, good). Free T3 2.6 (low-normal). Reverse T3 22 (high-normal). TPO antibodies 240 (still elevated). On paper, this patient is "well controlled" on levothyroxine. In practice, they're symptomatic because peripheral T4-to-T3 conversion is poor and reverse T3 is competing at the receptor. The pattern points toward additional T3 medication, stress/cortisol work, or a closer look at the autoimmune driver — none of which a single TSH check catches.
Example pattern · synthetic data
Questions to bring to your doctor
- What are my TPO antibodies, and have they been checked in the last 12 months?
- Is my free T4 (not just TSH) in the optimal third of the reference range, or just "in range"?
- Have we ever checked free T3 — and what was it?
- If I'm on levothyroxine and still tired, would you consider checking reverse T3 or trialing combination T4/T3 therapy?
- What's my trajectory — how do my TSH and antibodies compare to a year ago?
- Are there other autoimmune markers worth running given Hashimoto's overlap with celiac, vitiligo, and other autoimmune conditions?
- What's your view on the diet / lifestyle / micronutrient angle (selenium, vitamin D, iron, gluten trial) for autoimmune thyroid?
What Phi adds beyond a single number
A standard primary-care thyroid check usually reads TSH and maybe free T4, then declares "normal" or "high" based on whether each number falls inside a reference range. Phi reads the full panel — TSH + free T4 + free T3 + reverse T3 + TPO + TgAb — *together*, and against your own historical values. The integrated picture is what tells you whether the autoimmune process is active, whether peripheral conversion is the bottleneck, and whether the trajectory across 12–24 months is moving toward better or worse.
Upload your most recent lab report. Phi will pull out every thyroid-relevant marker, compare them against optimal (not just reference) ranges, flag the pattern, and tell you what to ask at your next appointment.
Frequently asked questions
Can I have Hashimoto's with a normal TSH?
Yes. TPO antibodies are often elevated years before TSH moves out of range. You can have active autoimmune thyroid disease with a "normal" TSH and still be symptomatic. The antibody result is what makes the diagnosis Hashimoto's specifically.
What's the difference between Hashimoto's and hypothyroidism?
Hypothyroidism is the functional state — your thyroid is underperforming. Hashimoto's is the cause in about 90% of US hypothyroid cases: your immune system attacks the thyroid gland. You can have Hashimoto's antibodies without yet being hypothyroid, and you can be hypothyroid from other causes (post-surgical, iodine deficiency, etc.).
Why does my TSH change between appointments?
TSH responds to recent stress, sleep, illness, time of day, and even what you ate that morning. Single-point readings can vary 20–30% in the same patient over a few weeks. Trajectory matters more than any individual draw.
Should I be worried about a slightly elevated TPO?
Elevated TPO means the autoimmune process is active, but it doesn't mean immediate medication. It is a strong signal to investigate root causes — vitamin D, gut health, gluten sensitivity, chronic stress, and selenium status are the most studied modifiable inputs.
My doctor says "your thyroid is fine" but I feel exhausted. What now?
Ask for the full panel (TSH + free T4 + free T3 + TPO + TgAb), not just TSH. "Fine on TSH" and "thyroid function is optimal" are different conclusions. If the panel still reads in range and you're symptomatic, the thyroid is only one part of the chronic-fatigue picture — adrenal/cortisol, iron, B12, sleep, and inflammation panels are worth running.
What's a reasonable TSH target if I'm on medication?
Most endocrinology guidelines target 0.5 – 2.5 mIU/L for treated patients (lower than the broader 0.4 – 4.5 reference range used for screening). Your own optimal may sit narrower; trajectory and symptom response over 3–6 months tell more than a single number.
Is Hashimoto's reversible?
The antibody process is generally lifelong, but antibody titers and symptom severity can decline substantially with the right inputs (anti-inflammatory diet, addressing nutrient deficiencies, gut health work, stress reduction). "Reversal" is too strong a word for most patients; "well-managed and largely asymptomatic" is realistic for many.
References
All citations verified against PubMed / publisher of record 2026-05-25.
- 1.Jonklaas J, Bianco AC, Bauer AJ, et al. (2014). Guidelines for the Treatment of Hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 24(12):1670-1751. — ATA current standard for hypothyroidism diagnosis and management; basis for TSH reference range discussion and treatment thresholds.PubMed →DOI →
- 2.Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MPJ. (2012). 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism. European Thyroid Journal. 1(2):55-71. — Basis for the 'treated but still symptomatic' discussion and combination T4/T3 therapy considerations.DOI →
- 3.Cooper DS, Biondi B. (2012). Subclinical thyroid disease. Lancet. 379(9821):1142-1154. — Standard reference on subclinical hypothyroidism management, including treatment thresholds in the 4.5–10 TSH range.PubMed →DOI →
- 4.Vanderpump MP, Tunbridge WM, French JM, et al. (1995). The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clinical Endocrinology (Oxf). 43(1):55-68. — Landmark prospective study establishing that elevated TPO antibodies predict progression to clinical hypothyroidism. Basis for 'TPO antibodies often elevate years before TSH moves' claim.PubMed →DOI →
- 5.Caturegli P, De Remigis A, Rose NR. (2014). Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmunity Reviews. 13(4-5):391-7. — Comprehensive clinical-diagnostic review; basis for prevalence and pattern descriptions.PubMed →DOI →
- 6.van Zuuren EJ, Albusta AY, Fedorowicz Z, Carter B, Pijl H. (2013). Selenium supplementation for Hashimoto's thyroiditis. Cochrane Database of Systematic Reviews. (6):CD010223. — Systematic review of selenium evidence in autoimmune thyroid; basis for the selenium mention in lifestyle/micronutrient inputs.PubMed →DOI →
- 7.Barbesino G. (2016). Misdiagnosis of Graves' Disease with Apparent Severe Hyperthyroidism in a Patient Taking Biotin Megadoses. Thyroid. 26(6):860-3. — Basis for the biotin-interference FAQ caveat.PubMed →DOI →
Reference ranges quoted are typical US clinical laboratory ranges (LabCorp / Quest); specific cutoffs vary by laboratory. Every link above opens the PubMed abstract or publisher's DOI landing page in a new tab. All citations verified vs PubMed / publisher of record 2026-05-25.
By Steve Pinedo
Co-founder, Phi Longevity
Pending clinical-team review · Last updated: 2026-05-25
Steve Pinedo is the Co-founder of Phi Longevity, the AI application that turns a confusing stack of lab reports, wearable data, and clinical notes into a single, integrated picture of your health. He started Phi Longevity to make proactive health and wellness far easier to achieve. He realized how difficult it was for clients to manage their own care, records and coordination so he assembled a comprehensive M.D. led clinical team behind the platform, packaging the proactive-care experience that delivered measurable outcomes (lower triglycerides, reduced body fat, improved LDL, balanced hormones, relief from long-running autoimmune conditions) for any patient with a complicated lab to use now with an application. More about Phi →